Claudia Rizzo

Cetuximab, docetaxel, and cisplatin versus platinum, fluorouracil, and cetuximab as first-line treatment in patients with recurrent or metastatic head and neck squamous-cell carcinoma (GORTEC 2014-01 TPExtreme): a multicentre, open-label, randomised, phase 2 trial

J. Guigay, Anne Aupérin, Jérôme Fayette et al. · The Lancet Oncology · 2021 · 214 citations

Gortec 2014-01 Tpextreme, Neoadjuvant Therapy, Medicine +11

Mean platelet volume and the extent of coronary artery disease: Results from a large prospective study

Giuseppe De Luca, Matteo Santagostino, Gioel Gabrio Secco et al. · Atherosclerosis · 2009 · 121 citations

Thrombosis, Large Prospective Study, Cardiovascular Disease +11

Pathophysiology of vascular dementia

Francesco Iemolo, Giovanni Duro, Claudia Rizzo et al. · Immunity & Ageing · 2009 · 74 citations · Full text

Aging, Alzheimer's Disease, Stroke +20

Lung cancer trends and tumor characteristic changes over 20 years (2000–2020): Results of three French consecutive nationwide prospective cohorts’ studies

D. Debieuvre, Olivier Molinier, L. Falchero et al. · The Lancet Regional Health - Europe · 2022 · 68 citations · Full text

Signaling through Ras Is Essential for retOncogene-induced Cell Differentiation in PC12 Cells

Daniela Califano, Claudia Rizzo, Amelia D’Alessio et al. · Journal of Biological Chemistry · 2000 · 67 citations · Full text

Cell Proliferation, Cell Specialization, Cellular Physiology +22